SNCA and Parkinson disease: Future research should focus on conducting large-scale, longitudinal studies to establish causality, standardizing microbiome analysis methods, evaluating FMT's impact on alpha-synuclein in humans, examining the relationship between PD medications and gut microbiome, developing personalized microbiome-based therapies, and identifying specific microbial markers for early diagnosis or preventive interventions.